Article: FDA Approves Celebrex(R) for Acute Pain Relief.

PEAPACK, N.J., Oct. 22 /PRNewswire/ --

Pharmacia Corporation and Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the use of CELEBREX(R) (celecoxib capsules) for the effective management of acute pain and primary dysmenorrhea (menstrual pain) in adults. Importantly, this new indication provides patients the benefit of being able to take an additional dose if needed for individualized relief of acute pain.

"With this approval CELEBREX has the broadest range of approved indications of any COX-2 specific inhibitor," said Carrie Cox, President of Pharmacia's Global Prescription Business. "We are pleased with the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!